LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
3.610
-0.020 (-0.55%)
At close: Dec 10, 2025, 4:00 PM EST
3.570
-0.040 (-1.11%)
Pre-market: Dec 11, 2025, 6:37 AM EST
LifeMD Market Cap
LifeMD has a market cap or net worth of $173.77 million as of December 11, 2025. Its market cap has decreased by -29.48% in one year.
Market Cap
173.77M
Enterprise Value
156.51M
1-Year Change
-29.48%
Ranking
Category
Stock Price
$3.61
Market Cap Chart
Since December 10, 2020, LifeMD's market cap has increased from $154.10M to $173.77M, an increase of 12.76%. That is a compound annual growth rate of 2.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 174.70M | -18.52% |
| Dec 31, 2024 | 214.40M | -31.89% |
| Dec 29, 2023 | 314.80M | 416.07% |
| Dec 30, 2022 | 61.00M | -48.48% |
| Dec 31, 2021 | 118.40M | -22.11% |
| Dec 31, 2020 | 152.00M | -1.36% |
| Dec 10, 2020 | 154.10M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 889.69B |
| Johnson & Johnson | 497.62B |
| AbbVie | 397.98B |
| UnitedHealth Group | 297.45B |
| AstraZeneca | 279.37B |
| Novartis AG | 251.91B |
| Merck & Co. | 242.30B |
| Thermo Fisher Scientific | 215.59B |